Onasemnogene Abeparvovec Gene Therapy in Presymptomatic spinal muscular atrophy (SMA): SPR1NT study update in children with 3 Copies of SMN2

被引:2
|
作者
Strauss, K. [1 ]
Muntoni, F. [2 ]
Farrar, M. [3 ]
Saito, K. [4 ]
Mendell, J. [5 ]
Servais, L. [6 ]
McMillan, H. [7 ]
Swoboda, K. [8 ]
Kwon, J. [9 ]
Zaidman, C. [10 ]
Chiriboga, C. [11 ]
Iannaccone, S. [12 ]
Krueger, J. [13 ]
Parsons, J. [14 ]
Shieh, P. [15 ]
Kavanagh, S. [16 ]
Chand, D. [16 ]
Tauscher-Wisniewski, S. [16 ]
Macek, T. [16 ]
机构
[1] Clin Special Children, Strasburg, PA USA
[2] UCL, London, England
[3] Sydney Childrens Hosp Network, Randwick, NSW, Australia
[4] Tokyo Womens Med Univ, Tokyo, Japan
[5] Nationwide Childrens Hosp, Columbus, OH USA
[6] MDUK Oxford Neuromuscular Ctr, Oxford, England
[7] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada
[8] Massachusetts Gen Hosp, Boston, MA 02114 USA
[9] Univ WI, Sch Med & Publ Hlth, Madison, WI USA
[10] Washington Univ, Sch Med, St Louis, MO USA
[11] Columbia Univ, Med Ctr, New York, NY USA
[12] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[13] Helen DeVos Childrens Hosp, Grand Rapids, MI USA
[14] Univ Colorado, Sch Med, Aurora, CO USA
[15] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[16] Novartis Gene Therapies, Bannockburn, IL USA
关键词
D O I
10.1016/j.nmd.2021.07.299
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EP.274
引用
收藏
页码:S133 / S133
页数:1
相关论文
共 50 条
  • [1] Onasemnogene Abeparvovec Gene Therapy in Presymptomatic Spinal Muscular Atrophy (SMA): SPR1NT Study Update in Children with 3 Copies of SMN2
    Strauss, Kevin
    Muntoni, Francesco
    Farrar, Michelle
    Saito, Kayoko
    Mendell, Jerry
    Servais, Laurent
    McMillan, Hugh
    Swoboda, Kathryn
    Kwon, Jennifer
    Zaidman, Craig
    Chiriboga, Claudia
    Iannaccone, Susan
    Krueger, Jena
    Parsons, Julie
    Shieh, Perry
    Kavanagh, Sarah
    Chand, Deepa
    Tauscher-Wisniewski, Sitra
    Macek, Thomas
    NEUROLOGY, 2021, 96 (15)
  • [2] Onasemnogene Abeparvovec Gene Therapy in Presymptomatic Spinal Muscular Atrophy (SMA): SPR1NT Study Update in Children with 3 Copies of SMN2
    McMillan, H.
    Strauss, K.
    Muntoni, F.
    Farrar, M.
    Saito, K.
    Mendell, J.
    Servais, L.
    Swoboda, K.
    Kwon, J.
    Zaidman, C.
    Chiriboga, C.
    Iannaccone, S.
    Krueger, J.
    Parsons, J.
    ANNALS OF NEUROLOGY, 2021, 90 : S152 - S152
  • [3] Onasemnogene abeparvovec gene therapy in presymptomatic spinal muscular atrophy (SMA): SPR1NT study update
    Strauss, K.
    Farrar, M.
    Swoboda, K.
    Saito, K.
    Chiriboga, C.
    Finkel, R.
    Iannaccone, S.
    Krueger, J.
    Kwon, J.
    McMillan, H.
    Servais, L.
    Mendell, J.
    Parsons, J.
    Scoto, M.
    Shieh, P.
    Zaidman, C.
    Schultz, M.
    Ogrinc, F.
    Group, S.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S122 - S122
  • [4] Onasemnogene Abeparvovec-xioi Gene Therapy in Presymptomatic Spinal Muscular Atrophy (SMA): SPR1NT Study Update
    Strauss, K. A.
    Farrar, M. A.
    Swoboda, K. J.
    Saito, K.
    Chiriboga, C. A.
    Finkel, R. S.
    Iannaccone, S. T.
    Krueger, J. M.
    Kwon, J. M.
    McMillan, H. J.
    Servais, L.
    Mendell, J. R.
    Parsons, J.
    Scoto, M.
    Shieh, P. B.
    Zaidman, C.
    Schultz, M.
    Baldinetti, F.
    Ogrinc, F. G.
    Kavanagh, S.
    Feltner, D. E.
    Tauscher-Wisniewski, S.
    McGill, B. E.
    Sproule, D. M.
    Muntoni, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 165 - 166
  • [5] Onasemnogene Abeparvovec in Presymptomatic Spinal Muscular Atrophy (SMA): SPRINT Study Update in Children with Three Copies of SMN2
    Strauss, Kevin
    Muntoni, Francesco
    Farrar, Michelle
    Saito, Kayoko
    Mendell, Jerry
    Servais, Laurent
    McMillan, Hugh
    Finkel, Richard
    Swoboda, Kathryn
    Kwon, Jennifer
    Zaidman, Craig
    Chiriboga, Claudia
    Lannaccone, Susan
    Krueger, Jena
    Parsons, Julie
    Shieh, Perry
    Kavanagh, Sarah
    Chand, Deepa
    Tauscher-Wisniewski, Sitra
    McGill, Bryan
    Macek, Thomas
    NEUROLOGY, 2022, 98 (18)
  • [6] Onasemnogene abeparvovec gene-replacement therapy (GRT) in presymptomatic spinal muscular atrophy (SMA): SPR1NT study update
    Strauss, K. A.
    Swoboda, K. J.
    Farrar, M. A.
    McMillan, H. J.
    Parsons, J.
    Krueger, J. M.
    Iannaccone, S. T.
    Chiriboga, C. A.
    Kwon, J. M.
    Saito, K.
    Scoto, M.
    Baldinetti, F.
    Schultz, M.
    Kernbauer, E.
    Farrow, M.
    Ogrinc, F. G.
    Kavanagh, S.
    Feltner, D. E.
    McGill, B. E.
    Spector, S. A.
    L'Italien, J.
    Sproule, D. M.
    Muntoni, F.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [7] Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
    Kevin A. Strauss
    Michelle A. Farrar
    Francesco Muntoni
    Kayoko Saito
    Jerry R. Mendell
    Laurent Servais
    Hugh J. McMillan
    Richard S. Finkel
    Kathryn J. Swoboda
    Jennifer M. Kwon
    Craig M. Zaidman
    Claudia A. Chiriboga
    Susan T. Iannaccone
    Jena M. Krueger
    Julie A. Parsons
    Perry B. Shieh
    Sarah Kavanagh
    Melissa Wigderson
    Sitra Tauscher-Wisniewski
    Bryan E. McGill
    Thomas A. Macek
    Nature Medicine, 2022, 28 : 1390 - 1397
  • [8] ONASEMNOGENE ABEPARVOVEC-XIOI GENE-REPLACEMENT THERAPY IN PRESYMPTOMATIC SPINAL MUSCULAR ATROPHY (SMA): SPR1NT STUDY UPDATE
    Strauss, Kevin A.
    Swoboda, Kathryn J.
    Farrar, Michelle A.
    McMillan, Hugh J.
    Parsons, Julie
    Krueger, Jena M.
    Iannaccone, Susan T.
    Chiriboga, Claudia A.
    Kwon, Jennifer M.
    Saito, Kayoko
    Scoto, Mariacristina
    Schultz, Meredith
    Kernbauer, Elaine
    Farrow, Marcia
    Ogrinc, Francis G.
    Kavanagh, Sarah
    Feltner, Douglas E.
    McGill, Bryan E.
    Meriggioli, Matthew
    L'ltalien, James
    Sproule, Douglas M.
    Muntoni, Francesco
    MUSCLE & NERVE, 2019, 60 : S13 - S13
  • [9] Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
    Strauss, Kevin A.
    Farrar, Michelle A.
    Muntoni, Francesco
    Saito, Kayoko
    Mendell, Jerry R.
    Servais, Laurent
    McMillan, Hugh J.
    Finkel, Richard S.
    Swoboda, Kathryn J.
    Kwon, Jennifer M.
    Zaidman, Craig M.
    Chiriboga, Claudia A.
    Iannaccone, Susan T.
    Krueger, Jena M.
    Parsons, Julie A.
    Shieh, Perry B.
    Kavanagh, Sarah
    Tauscher-Wisniewski, Sitra
    McGill, Bryan E.
    Macek, Thomas A.
    NATURE MEDICINE, 2022, 28 (07) : 1381 - +
  • [10] Onasemnogene Abeparvovec-xioi Gene-Replacement Therapy in Presymptomatic Spinal Muscular Atrophy: SPR1NT Study Update
    Strauss, Kevin A.
    Farrar, Michelle A.
    Swoboda, Kathryn J.
    Saito, Kayoko
    Chiriboga, Claudia A.
    Finkel, Richard S.
    Iannaccone, Susan T.
    Krueger, Jena M.
    Kwon, Jennifer M.
    McMillan, Hugh J.
    Servais, Laurent
    Mendell, Jerry R.
    Parsons, Julie
    Scoto, Mariacristina
    Shieh, Perry B.
    Zaidman, Craig
    Schultz, Meredith
    Kernbauer, Elaine
    Joshi, Shivani
    Ogrinc, Francis G.
    Kavanagh, Sarah
    Feltner, Douglas E.
    Tauscher-Wisniewski, Sitra
    McGill, Bryan E.
    Sproule, Douglas M.
    Muntoni, Francesco
    NEUROLOGY, 2020, 94 (15)